Editorial - Avoiding UnethicalHelicobacter pyloriClinical Trials: Susceptibility-Based Studies and Probiotics as Adjuvants
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Editorial - Avoiding UnethicalHelicobacter pyloriClinical Trials: Susceptibility-Based Studies and Probiotics as Adjuvants
Authors
Keywords
-
Journal
HELICOBACTER
Volume 20, Issue 5, Pages 321-325
Publisher
Wiley
Online
2015-06-30
DOI
10.1111/hel.12244
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Helicobacter pylori Update: Gastric Cancer, Reliable Therapy, and Possible Benefits
- (2015) David Y. Graham GASTROENTEROLOGY
- Pretreatment Antimicrobial Susceptibility-Guided Vs. Clarithromycin-Based Triple Therapy for Helicobacter pylori Eradication in a Region With High Rates of Multiple Drug Resistance
- (2014) Chung-Su Park et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- High-Dose Extended-Release Lansoprazole (Dexlansoprazole) and Amoxicillin Dual Therapy forHelicobacter pyloriInfections
- (2014) Taraq A. Attumi et al. HELICOBACTER
- The Effect of Probiotics Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis
- (2014) Yini Dang et al. PLoS One
- Lactobacillus -containing probiotic supplementation increases Helicobacter pylori eradication rate: evidence from a meta-analysis
- (2014) Xi Zheng et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- Probiotics for Helicobacter pylori eradication therapy: not ready for prime time
- (2014) Javier Molina-Infante et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- Culture-guided treatment approach forHelicobacter pyloriinfection: Review of the literature
- (2014) Giovanni Cammarota WORLD JOURNAL OF GASTROENTEROLOGY
- Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
- (2013) David Y. Graham et al. Clinical Gastroenterology and Hepatology
- Eradication of Helicobacter pylori According to 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance
- (2013) H. J. Lee et al. JOURNAL OF INFECTIOUS DISEASES
- Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
- (2013) L. Gatta et al. BMJ-British Medical Journal
- Meta-Analysis of the Efficacy and Safety of Lactobacillus-containing and Bifidobacterium-containing Probiotic Compound Preparation in Helicobacter pylori Eradication Therapy
- (2012) Zhen-Hua Wang et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial
- (2011) E Robert Greenberg et al. LANCET
- Helicobacter pylori Eradication Therapy Research: Ethical Issues and Description of Results
- (2010) David Y. Graham Clinical Gastroenterology and Hepatology
- Equipoise, H. pylori, and Musketeers – Choosing an Appropriate Standard Clinical Care Regimen
- (2008) William J Tremaine HELICOBACTER
- Tailored eradication therapy based on fecalHelicobacter pyloriclarithromycin sensitivities
- (2008) Takashi Kawai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now